Beyond Triple Therapy: Anti-Type 2 Biologic Therapies for Eosinophilic COPD and Respiratory Comorbidities - a Review of Clinical Evidence. - Mari PV; Carriera L; Ielo S; Di Michele L; Fontana DO; Ricci A; Coppola A; Selvaggio D; Caruso C; Gambacorta V; Stivalini D; Lipsi R; et al. (Current allergy and asthma reports, 2026)